iSpecimen Inc. Capital Expenditures
iSpecimen Inc. (ISPC) reported Capital Expenditures of $454 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- iSpecimen Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- iSpecimen Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- iSpecimen Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $7.87K.
- iSpecimen Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $14.54K, a 153.71% increase year-over-year.
- iSpecimen Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $454.00, a 98.56% decline from fiscal 2024.
- iSpecimen Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $31.55K, a 61.96% increase from fiscal 2023.
- iSpecimen Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $19.48K, a 90.96% decline from fiscal 2022.
- iSpecimen Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $215.50K, a 8351.14% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $0.00 derived: sum of 2 quarters · filed 2026-04-01 | $454.00 10-K · filed 2026-04-01 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $454.00 10-Q · filed 2025-11-17 | ||
| 2025-06-30 | $454.00 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $7.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $22.41K derived: sum of 2 quarters · filed 2026-04-01 | $22.41K derived: sum of 3 quarters · filed 2026-04-01 | $31.55K 10-K · filed 2026-04-01 |
| 2024-09-30 | $14.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $14.54K derived: sum of 2 quarters · filed 2025-11-17 | $23.68K 10-Q · filed 2025-11-17 | $23.68K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.14K 10-Q · filed 2025-08-14 | $9.14K derived: sum of 3 quarters · filed 2025-08-14 | $14.87K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $9.14K 10-Q · filed 2025-05-19 | $9.14K derived: sum of 2 quarters · filed 2025-05-19 | $14.87K derived: sum of 3 quarters · filed 2025-05-19 | $20.58K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | $5.73K derived: sum of 2 quarters · filed 2025-04-14 | $11.45K derived: sum of 3 quarters · filed 2025-04-14 | $19.48K 10-K · filed 2025-04-14 |
| 2023-09-30 | $5.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.45K derived: sum of 2 quarters · filed 2024-11-07 | $19.48K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $5.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $13.74K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $8.03K 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $215.50K 10-K · filed 2024-03-13 | |||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $2.55K 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.55K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $2.55K 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | -$580.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$581.00 derived: sum of 2 quarters · filed 2022-03-22 | $426.00 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.01K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $1.01K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |